Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy. (2nd September 2021) - Gastinne, Thomas; Le Bourgeois, Amandine; Coste‐Burel, Marianne; Guillaume, Thierry; Peterlin, Pierre; Garnier, Alice; Imbert, Berthe‐Marie; Drumel, Thomas; Mahe, Beatrice; Dubruille, Viviane; Blin, Nicolas; Lok, Anne; et al.